Clinical Trials Logo

Lateral Canthal Lines, LCL clinical trials

View clinical trials related to Lateral Canthal Lines, LCL.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04247074 Completed - Clinical trials for Glabellar Frown Lines (GL)

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

READY-3
Start date: February 10, 2020
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

NCT ID: NCT03912805 Completed - Crow's Feet Clinical Trials

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Start date: February 27, 2019
Phase: Phase 2
Study type: Interventional

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).